# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-057359
Filing Date
2025-04-23
Accepted
2025-04-23 16:10:42
Documents
5
Period of Report
2025-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | sera-def14a-2025.htm | DEF 14A | 1060745
2 | GRAPHIC | img222552585_0.jpg | GRAPHIC | 1203274
3 | GRAPHIC | img222552585_1.jpg | GRAPHIC | 68799
4 | GRAPHIC | img222552585_2.jpg | GRAPHIC | 432262
5 | GRAPHIC | img222552585_3.jpg | GRAPHIC | 248868
| Complete submission text file | 0000950170-25-057359.txt |  | 3581862

Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40606 | Film No.: 25861563
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)